{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:04:13Z","timestamp":1792760653014,"version":"4.5.0"},"reference-count":173,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s12272-020-01296-1","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T12:36:46Z","timestamp":1609763806000},"page":"117-132","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["IL-1 and CD40\/CD40L platelet complex: elements of induction of Crohn\u2019s disease and new therapeutic targets"],"prefix":"10.1007","volume":"44","author":[{"given":"Doha","family":"Anka Idrissi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nezha","family":"Senhaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmae","family":"Aouiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loubna","family":"Khalki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youssef","family":"Tijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"Zaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima Zahra","family":"Marhoume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah","family":"Naya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mounia","family":"Oudghiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Kabine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8750-9106","authenticated-orcid":false,"given":"Younes","family":"Zaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,4]]},"reference":[{"key":"1296_CR1","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2018.1447597","author":"B Ahluwalia","year":"2018","unstructured":"Ahluwalia B, Moraes L, Magnusson MK, Ohman L (2018) Immunopathogenesis of inflammatory bowel disease and mechanisms of biological therapies. Scand J Gastroenterol. https:\/\/doi.org\/10.1080\/00365521.2018.1447597","journal-title":"Scand J Gastroenterol"},{"key":"1296_CR2","doi-asserted-by":"publisher","first-page":"490148","DOI":"10.1155\/2012\/490148","volume":"2012","author":"N Alaaeddine","year":"2012","unstructured":"Alaaeddine N, Hassan GS, Yacoub D, Mourad W (2012) CD154: an immunoinflammatory mediator in systemic lupus erythematosus and rheumatoid arthritis. Clin Dev Immunol 2012:490148. https:\/\/doi.org\/10.1155\/2012\/490148","journal-title":"Clin Dev Immunol"},{"key":"1296_CR3","doi-asserted-by":"publisher","first-page":"22342","DOI":"10.3390\/ijms151222342","volume":"15","author":"C Aloui","year":"2014","unstructured":"Aloui C, Prigent A, Sut C, Hamzeh-Cognasse H, Pozzetto B, Richard Y, Cognasse F, Laradi S, Garraud O (2014) The signaling role of CD40 ligand in platelet biology and in platelet component transfusion. Int J Mol Sci 15:22342\u201322364. https:\/\/doi.org\/10.3390\/ijms151222342","journal-title":"Int J Mol Sci"},{"key":"1296_CR4","doi-asserted-by":"publisher","first-page":"11226","DOI":"10.1074\/jbc.M110.208215","volume":"286","author":"HJ An","year":"2011","unstructured":"An HJ, Kim YJ, Song DH, Park BS, Kim HM, Lee JD, Paik SG, Lee JO, Lee H (2011) Crystallographic and mutational analysis of the CD40-CD154 complex and its implications for receptor activation. J Biol Chem 286:11226\u201311235. https:\/\/doi.org\/10.1074\/jbc.M110.208215","journal-title":"J Biol Chem"},{"key":"1296_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1160\/TH03-05-0268","volume":"90","author":"SX Anand","year":"2003","unstructured":"Anand SX, Viles-Gonzalez JF, Badimon JJ, Cavusoglu E, Marmur JD (2003) Membrane-associated CD40L and sCD40L in atherothrombotic disease. Thromb Haemost 90:377\u2013384. https:\/\/doi.org\/10.1160\/TH03-05-0268","journal-title":"Thromb Haemost"},{"key":"1296_CR6","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nm0302-247","volume":"8","author":"P Andre","year":"2002","unstructured":"Andre P, Prasad KS, Denis CV, He M, Papalia JM, Hynes RO, Phillips DR, Wagner DD (2002) CD40L stabilizes arterial thrombi by a beta3 integrin\u2014dependent mechanism. Nat Med 8:247\u2013252. https:\/\/doi.org\/10.1038\/nm0302-247","journal-title":"Nat Med"},{"key":"1296_CR7","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.jacc.2009.03.076","volume":"54","author":"C Antoniades","year":"2009","unstructured":"Antoniades C, Bakogiannis C, Tousoulis D, Antonopoulos AS, Stefanadis C (2009) The CD40\/CD40 ligand system: linking inflammation with atherothrombosis. J Am Coll Cardiol 54:669\u2013677. https:\/\/doi.org\/10.1016\/j.jacc.2009.03.076","journal-title":"J Am Coll Cardiol"},{"key":"1296_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.retram.2019.01.005","volume":"67","author":"A Aouiss","year":"2019","unstructured":"Aouiss A, Anka Idrissi D, Kabine M, Zaid Y (2019) Update of inflammatory proliferative retinopathy: ischemia, hypoxia and angiogenesis. Curr Res Transl Med 67:62\u201371. https:\/\/doi.org\/10.1016\/j.retram.2019.01.005","journal-title":"Curr Res Transl Med"},{"key":"1296_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BJ20140712","volume":"462","author":"JJ Babon","year":"2014","unstructured":"Babon JJ, Lucet IS, Murphy JM, Nicola NA, Varghese LN (2014) The molecular regulation of Janus kinase (JAK) activation. Biochem J 462:1\u201313. https:\/\/doi.org\/10.1042\/BJ20140712","journal-title":"Biochem J"},{"key":"1296_CR10","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1136\/gut.2009.197822","volume":"59","author":"C Bauer","year":"2010","unstructured":"Bauer C, Duewell P, Mayer C, Lehr HA, Fitzgerald KA, Dauer M, Tschopp J, Endres S, Latz E, Schnurr M (2010) Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut 59:1192\u20131199. https:\/\/doi.org\/10.1136\/gut.2009.197822","journal-title":"Gut"},{"issue":"Suppl 1","key":"1296_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1159\/000341681","volume":"30","author":"C Bauer","year":"2012","unstructured":"Bauer C, Duewell P, Lehr HA, Endres S, Schnurr M (2012) Protective and aggravating effects of Nlrp3 inflammasome activation in IBD models: influence of genetic and environmental factors. Dig Dis 30(Suppl 1):82\u201390. https:\/\/doi.org\/10.1159\/000341681","journal-title":"Dig Dis"},{"key":"1296_CR12","doi-asserted-by":"publisher","first-page":"25032","DOI":"10.1074\/jbc.M204003200","volume":"277","author":"U Bavendiek","year":"2002","unstructured":"Bavendiek U, Libby P, Kilbride M, Reynolds R, Mackman N, Schonbeck U (2002) Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor kappa B, and Egr-1. J Biol Chem 277:25032\u201325039. https:\/\/doi.org\/10.1074\/jbc.M204003200","journal-title":"J Biol Chem"},{"key":"1296_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.blre.2009.04.001","volume":"23","author":"P Blair","year":"2009","unstructured":"Blair P, Flaumenhaft R (2009) Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 23:177\u2013189. https:\/\/doi.org\/10.1016\/j.blre.2009.04.001","journal-title":"Blood Rev"},{"key":"1296_CR14","doi-asserted-by":"publisher","first-page":"e84289","DOI":"10.1371\/journal.pone.0084289","volume":"8","author":"L Bou Khzam","year":"2013","unstructured":"Bou Khzam L, Boulahya R, Abou-Saleh H, Hachem A, Zaid Y, Merhi Y (2013) Soluble CD40 ligand stimulates the pro-angiogenic function of peripheral blood angiogenic outgrowth cells via increased release of matrix metalloproteinase-9. PLoS ONE 8:e84289. https:\/\/doi.org\/10.1371\/journal.pone.0084289","journal-title":"PLoS ONE"},{"key":"1296_CR15","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1160\/TH12-09-0679","volume":"109","author":"L Bou Khzam","year":"2013","unstructured":"Bou Khzam L, Hachem A, Zaid Y, Boulahya R, Mourad W, Merhi Y (2013) Soluble CD40 ligand impairs the anti-platelet function of peripheral blood angiogenic outgrowth cells via increased production of reactive oxygen species. Thromb Haemost 109:940\u2013947. https:\/\/doi.org\/10.1160\/TH12-09-0679","journal-title":"Thromb Haemost"},{"key":"1296_CR16","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4049\/jimmunol.142.2.562","volume":"142","author":"S Braesch-Andersen","year":"1989","unstructured":"Braesch-Andersen S, Paulie S, Koho H, Nika H, Aspenstrom P, Perlmann P (1989) Biochemical characteristics and partial amino acid sequence of the receptor-like human B cell and carcinoma antigen CDw40. J Immunol 142:562\u2013567","journal-title":"J Immunol"},{"issue":"212\u2013224","key":"1296_CR17","doi-asserted-by":"publisher","first-page":"e4","DOI":"10.1016\/j.immuni.2018.12.015","volume":"50","author":"GJ Britton","year":"2019","unstructured":"Britton GJ, Contijoch EJ, Mogno I, Vennaro OH, Llewellyn SR, Ng R, Li Z, Mortha A, Merad M, Das A, Gevers D, McGovern DPB, Singh N, Braun J, Jacobs JP, Clemente JC, Grinspan A, Sands BE, Colombel JF, Dubinsky MC, Faith JJ (2019) Microbiotas from humans with inflammatory bowel disease alter the balance of gut Th17 and RORgammat(+) regulatory T cells and exacerbate colitis in mice. Immunity 50(212\u2013224):e4. https:\/\/doi.org\/10.1016\/j.immuni.2018.12.015","journal-title":"Immunity"},{"issue":"900\u2013912","key":"1296_CR18","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.jaci.2016.07.018","volume":"139","author":"O Cabral-Marques","year":"2017","unstructured":"Cabral-Marques O, Ramos RN, Schimke LF, Khan TA, Amaral EP, Barbosa Bomfim CC, Junior OR, Franca TT, Arslanian C, Carola Correia Lima JD, Weber CW, Ferreira JF, Tavares FS, Sun J, D\u2019Imperio Lima MR, Seelaender M, Garcia Calich VL, Marzagao Barbuto JA, Costa-Carvalho BT, Riemekasten G, Seminario G, Bezrodnik L, Notarangelo L, Torgerson TR, Ochs HD, Condino-Neto A (2017) Human CD40 ligand deficiency dysregulates the macrophage transcriptome causing functional defects that are improved by exogenous IFN-gamma. J Allergy Clin Immunol 139(900\u2013912):e7. https:\/\/doi.org\/10.1016\/j.jaci.2016.07.018","journal-title":"J Allergy Clin Immunol"},{"key":"1296_CR19","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/0167-5699(93)90188-Q","volume":"14","author":"RE Callard","year":"1993","unstructured":"Callard RE, Armitage RJ, Fanslow WC, Spriggs MK (1993) CD40 ligand and its role in X-linked hyper-IgM syndrome. Immunol Today 14:559\u2013564. https:\/\/doi.org\/10.1016\/0167-5699(93)90188-Q","journal-title":"Immunol Today"},{"key":"1296_CR20","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1161\/01.ATV.0000184765.59207.f3","volume":"25","author":"S Chakrabarti","year":"2005","unstructured":"Chakrabarti S, Varghese S, Vitseva O, Tanriverdi K, Freedman JE (2005) CD40 ligand influences platelet release of reactive oxygen intermediates. Arter Thromb Vasc Biol 25:2428\u20132434. https:\/\/doi.org\/10.1161\/01.ATV.0000184765.59207.f3","journal-title":"Arter Thromb Vasc Biol"},{"key":"1296_CR21","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1111\/j.1600-6143.2012.04241.x","volume":"12","author":"AH Charafeddine","year":"2012","unstructured":"Charafeddine AH, Kim EJ, Maynard DM, Yi H, Weaver TA, Gunay-Aygun M, Russell M, Gahl WA, Kirk AD (2012) Platelet-derived CD154: ultrastructural localization and clinical correlation in organ transplantation. Am J Transpl 12:3143\u20133151. https:\/\/doi.org\/10.1111\/j.1600-6143.2012.04241.x","journal-title":"Am J Transpl"},{"key":"1296_CR22","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1053\/j.gastro.2017.09.029","volume":"153","author":"A Chauhan","year":"2017","unstructured":"Chauhan A, Adams DH (2017) Platelets are critical drivers of illness behaviors during liver inflammation. Gastroenterology 153:1188\u20131190. https:\/\/doi.org\/10.1053\/j.gastro.2017.09.029","journal-title":"Gastroenterology"},{"key":"1296_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2174\/1389450116666150113122229","volume":"16","author":"C Chen","year":"2015","unstructured":"Chen C, Li Y, Yu Z, Liu Z, Shi Y, Lewandowska U, Sobczak M, Fichna J, Kreis M (2015) Platelet activity in the pathophysiology of inflammatory bowel diseases. Curr Drug Targets 16:219\u2013225. https:\/\/doi.org\/10.2174\/1389450116666150113122229","journal-title":"Curr Drug Targets"},{"key":"1296_CR24","doi-asserted-by":"publisher","first-page":"338","DOI":"10.3748\/wjg.14.338","volume":"14","author":"JH Cho","year":"2008","unstructured":"Cho JH (2008) Inflammatory bowel disease: genetic and epidemiologic considerations. World J Gastroenterol 14:338\u2013347. https:\/\/doi.org\/10.3748\/wjg.14.338","journal-title":"World J Gastroenterol"},{"key":"1296_CR25","doi-asserted-by":"publisher","first-page":"598","DOI":"10.20452\/pamw.15463","volume":"130","author":"D Cibor","year":"2020","unstructured":"Cibor D, Szczeklik K, Koziol K, Pocztar H, Mach T, Owczarek D (2020) Serum concentration of selected biochemical markers of endothelial dysfunction and inflammation in patients with the varying activity of inflammatory bowel disease. Pol Arch Intern Med 130:598\u2013606. https:\/\/doi.org\/10.20452\/pamw.15463","journal-title":"Pol Arch Intern Med"},{"key":"1296_CR26","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.exphem.2007.05.021","volume":"35","author":"F Cognasse","year":"2007","unstructured":"Cognasse F, Hamzeh-Cognasse H, Lafarge S, Chavarin P, Cogne M, Richard Y, Garraud O (2007) Human platelets can activate peripheral blood B cells and increase production of immunoglobulins. Exp Hematol 35:1376\u20131387. https:\/\/doi.org\/10.1016\/j.exphem.2007.05.021","journal-title":"Exp Hematol"},{"key":"1296_CR27","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1097\/MPG.0000000000000449","volume":"59","author":"SA Cohen","year":"2014","unstructured":"Cohen SA, Gold BD, Oliva S, Lewis J, Stallworth A, Koch B, Eshee L, Mason D (2014) Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease. J Pediatr Gastroenterol Nutr 59:516\u2013521. https:\/\/doi.org\/10.1097\/MPG.0000000000000449","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1296_CR28","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/cei.12649","volume":"181","author":"Corrigendum","year":"2015","unstructured":"Corrigendum, Longhurst HJ, Tarzi MD, Ashworth F, Bethune C, Cale C, Dempster J, Gompels M, Jolles S, Seneviratne S, Symons C, Price A, Edgar D (2015) C1 inhibitor deficiency: 2014 United Kingdom consensus document. Clin Exp Immunol 181:188. https:\/\/doi.org\/10.1111\/cei.12649","journal-title":"Clin Exp Immunol"},{"key":"1296_CR29","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1053\/j.gastro.2011.01.055","volume":"140","author":"J Cosnes","year":"2011","unstructured":"Cosnes J, Gower-Rousseau C, Seksik P, Cortot A (2011) Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 140:1785\u20131794. https:\/\/doi.org\/10.1053\/j.gastro.2011.01.055","journal-title":"Gastroenterology"},{"key":"1296_CR30","first-page":"251","volume":"225","author":"JB Cotton","year":"1971","unstructured":"Cotton JB (1971) Use of solumedrol in pediatrics. Apropos of 45 cases. Lyon Med 225:251\u2013254","journal-title":"Lyon Med"},{"key":"1296_CR31","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1136\/gut.52.10.1435","volume":"52","author":"S Danese","year":"2003","unstructured":"Danese S, Katz JA, Saibeni S, Papa A, Gasbarrini A, Vecchi M, Fiocchi C (2003) Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 52:1435\u20131441. https:\/\/doi.org\/10.1136\/gut.52.10.1435","journal-title":"Gut"},{"key":"1296_CR32","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.4049\/jimmunol.172.4.2011","volume":"172","author":"S Danese","year":"2004","unstructured":"Danese S, de la Motte C, Reyes BM, Sans M, Levine AD, Fiocchi C (2004) Cutting edge: T cells trigger CD40-dependent platelet activation and granular RANTES release: a novel pathway for immune response amplification. J Immunol 172:2011\u20132015. https:\/\/doi.org\/10.4049\/jimmunol.172.4.2011","journal-title":"J Immunol"},{"key":"1296_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","volume":"13","author":"HS de Souza","year":"2016","unstructured":"de Souza HS, Fiocchi C (2016) Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol 13:13\u201327. https:\/\/doi.org\/10.1038\/nrgastro.2015.186","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1296_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/MEG.0b013e328365c372","volume":"26","author":"PS de Silva","year":"2014","unstructured":"de Silva PS, Luben R, Shrestha SS, Khaw KT, Hart AR (2014) Dietary arachidonic and oleic acid intake in ulcerative colitis etiology: a prospective cohort study using 7-day food diaries. Eur J Gastroenterol Hepatol 26:11\u201318. https:\/\/doi.org\/10.1097\/MEG.0b013e328365c372","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1296_CR35","first-page":"66","volume":"65","author":"DI Dejica","year":"2006","unstructured":"Dejica DI, Manea EM (2006) Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therap Perspect Roum Arch Microbiol Immunol 65:66\u201374","journal-title":"Therap Perspect Roum Arch Microbiol Immunol"},{"key":"1296_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.0906-6713.2004.003569.x","volume":"35","author":"N Delaleu","year":"2004","unstructured":"Delaleu N, Bickel M (2004) Interleukin-1 beta and interleukin-18: regulation and activity in local inflammation. Periodontol 2000 35:42\u201352. https:\/\/doi.org\/10.1111\/j.0906-6713.2004.003569.x","journal-title":"Periodontol 2000"},{"key":"1296_CR37","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1051\/medsci\/20052110825","volume":"21","author":"Y Delmas","year":"2005","unstructured":"Delmas Y, Viallard JF, Villeneuve J, Grosset C, Pasquet JM, Dechanet-Merville J, Nurden P, Pellegrin JL, Rosenbaum J, Combe C, Nurden AT, Ripoche J (2005) Platelet-associated CD154: a new interface in haemostasis and in the inflammatory reaction. Med Sci Paris 21:825\u2013831. https:\/\/doi.org\/10.1051\/medsci\/20052110825","journal-title":"Med Sci Paris"},{"key":"1296_CR38","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.cell.2005.06.015","volume":"122","author":"MM Denis","year":"2005","unstructured":"Denis MM, Tolley ND, Bunting M, Schwertz H, Jiang H, Lindemann S, Yost CC, Rubner FJ, Albertine KH, Swoboda KJ, Fratto CM, Tolley E, Kraiss LW, McIntyre TM, Zimmerman GA, Weyrich AS (2005) Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell 122:379\u2013391. https:\/\/doi.org\/10.1016\/j.cell.2005.06.015","journal-title":"Cell"},{"key":"1296_CR39","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1160\/TH16-02-0167","volume":"116","author":"A Di Sabatino","year":"2016","unstructured":"Di Sabatino A, Santilli F, Guerci M, Simeone P, Ardizzone S, Massari A, Giuffrida P, Tripaldi R, Malara A, Liani R, Gurini E, Aronico N, Balduini A, Corazza GR, Davi G (2016) Oxidative stress and thromboxane-dependent platelet activation in inflammatory bowel disease: effects of anti-TNF-alpha treatment. Thromb Haemost 116:486\u2013495. https:\/\/doi.org\/10.1160\/TH16-02-0167","journal-title":"Thromb Haemost"},{"key":"1296_CR40","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/s1359-6101(97)00023-3","volume":"8","author":"CA Dinarello","year":"1997","unstructured":"Dinarello CA (1997) Interleukin-1. Cytokine Growth Factor Rev 8:253\u2013265. https:\/\/doi.org\/10.1016\/s1359-6101(97)00023-3","journal-title":"Cytokine Growth Factor Rev"},{"key":"1296_CR41","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.coph.2004.03.010","volume":"4","author":"CA Dinarello","year":"2004","unstructured":"Dinarello CA (2004) Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation. Curr Opin Pharmacol 4:378\u2013385. https:\/\/doi.org\/10.1016\/j.coph.2004.03.010","journal-title":"Curr Opin Pharmacol"},{"key":"1296_CR42","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","volume":"117","author":"CA Dinarello","year":"2011","unstructured":"Dinarello CA (2011) Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117:3720\u20133732. https:\/\/doi.org\/10.1182\/blood-2010-07-273417","journal-title":"Blood"},{"key":"1296_CR43","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nrd3800","volume":"11","author":"CA Dinarello","year":"2012","unstructured":"Dinarello CA, Simon A, van der Meer JW (2012) Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov 11:633\u2013652. https:\/\/doi.org\/10.1038\/nrd3800","journal-title":"Nat Rev Drug Discov"},{"key":"1296_CR44","doi-asserted-by":"publisher","first-page":"15219","DOI":"10.1038\/s41598-017-15412-7","volume":"7","author":"JC Dos Santos","year":"2017","unstructured":"Dos Santos JC, Damen M, Oosting M, de Jong DJ, Heinhuis B, Gomes RS, Araujo CS, Netea MG, Ribeiro-Dias F, Joosten LAB (2017) The NOD2 receptor is crucial for immune responses towards New World Leishmania species. Sci Rep 7:15219. https:\/\/doi.org\/10.1038\/s41598-017-15412-7","journal-title":"Sci Rep"},{"key":"1296_CR45","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","volume":"229","author":"R Elgueta","year":"2009","unstructured":"Elgueta R, Benson MJ, de Vries VC, Wasiuk A, Guo Y, Noelle RJ (2009) Molecular mechanism and function of CD40\/CD40L engagement in the immune system. Immunol Rev 229:152\u2013172. https:\/\/doi.org\/10.1111\/j.1600-065X.2009.00782.x","journal-title":"Immunol Rev"},{"key":"1296_CR46","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/S0195-6663(85)80017-9","volume":"6","author":"SR Ellins","year":"1985","unstructured":"Ellins SR (1985) Coyote control and taste aversion: a predation problem or a people problem? Appetite 6:272\u2013275. https:\/\/doi.org\/10.1016\/S0195-6663(85)80017-9","journal-title":"Appetite"},{"key":"1296_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/s1074-7613(03)00177-8","volume":"19","author":"BD Elzey","year":"2003","unstructured":"Elzey BD, Tian J, Jensen RJ, Swanson AK, Lees JR, Lentz SR, Stein CS, Nieswandt B, Wang Y, Davidson BL, Ratliff TL (2003) Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity 19:9\u201319. https:\/\/doi.org\/10.1016\/s1074-7613(03)00177-8","journal-title":"Immunity"},{"key":"1296_CR48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1189\/jlb.1104669","volume":"78","author":"BD Elzey","year":"2005","unstructured":"Elzey BD, Grant JF, Sinn HW, Nieswandt B, Waldschmidt TJ, Ratliff TL (2005) Cooperation between platelet-derived CD154 and CD4+ T cells for enhanced germinal center formation. J Leukoc Biol 78:80\u201384. https:\/\/doi.org\/10.1189\/jlb.1104669","journal-title":"J Leukoc Biol"},{"key":"1296_CR49","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1006\/smim.1994.1035","volume":"6","author":"WC Fanslow","year":"1994","unstructured":"Fanslow WC, Srinivasan S, Paxton R, Gibson MG, Spriggs MK, Armitage RJ (1994) Structural characteristics of CD40 ligand that determine biological function. Semin Immunol 6:267\u2013278. https:\/\/doi.org\/10.1006\/smim.1994.1035","journal-title":"Semin Immunol"},{"key":"1296_CR50","doi-asserted-by":"publisher","first-page":"250","DOI":"10.12998\/wjcc.v2.i7.250","volume":"2","author":"A Farrukh","year":"2014","unstructured":"Farrukh A, Mayberry JF (2014) Is there a role for fish oil in inflammatory bowel disease? World J Clin Cases 2:250. https:\/\/doi.org\/10.12998\/wjcc.v2.i7.250","journal-title":"World J Clin Cases"},{"key":"1296_CR51","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3748\/wjg.v17.i5.557","volume":"17","author":"F Fava","year":"2011","unstructured":"Fava F, Danese S (2011) Intestinal microbiota in inflammatory bowel disease: friend of foe? World J Gastroenterol 17:557\u2013566. https:\/\/doi.org\/10.3748\/wjg.v17.i5.557","journal-title":"World J Gastroenterol"},{"key":"1296_CR52","doi-asserted-by":"publisher","first-page":"1756283X1774502","DOI":"10.1177\/1756283X17745029","volume":"11","author":"M Flamant","year":"2018","unstructured":"Flamant M, Roblin X (2018) Inflammatory bowel disease: towards a personalized medicine. Ther Adv Gastroenterol 11:1756283X17745029. https:\/\/doi.org\/10.1177\/1756283X17745029","journal-title":"Ther Adv Gastroenterol"},{"key":"1296_CR53","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1161\/01.ATV.0000075965.88456.48","volume":"23","author":"R Flaumenhaft","year":"2003","unstructured":"Flaumenhaft R (2003) Molecular basis of platelet granule secretion. Arter Thromb Vasc Biol 23:1152\u20131160. https:\/\/doi.org\/10.1161\/01.ATV.0000075965.88456.48","journal-title":"Arter Thromb Vasc Biol"},{"key":"1296_CR54","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nrrheum.2010.4","volume":"6","author":"C Gabay","year":"2010","unstructured":"Gabay C, Lamacchia C, Palmer G (2010) IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol 6:232\u2013241. https:\/\/doi.org\/10.1038\/nrrheum.2010.4","journal-title":"Nat Rev Rheumatol"},{"key":"1296_CR55","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1152\/physrev.1989.69.1.58","volume":"197","author":"C Gachet","year":"2013","unstructured":"Gachet C (2013) Molecular mechanisms of platelet activation. Bull Acad Natl Med 197:361\u2013373. https:\/\/doi.org\/10.1152\/physrev.1989.69.1.58","journal-title":"Bull Acad Natl Med"},{"key":"1296_CR56","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","volume":"39","author":"C Garlanda","year":"2013","unstructured":"Garlanda C, Dinarello CA, Mantovani A (2013) The interleukin-1 family: back to the future. Immunity 39:1003\u20131018. https:\/\/doi.org\/10.1016\/j.immuni.2013.11.010","journal-title":"Immunity"},{"key":"1296_CR57","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.thromres.2010.10.015","volume":"127","author":"O Garraud","year":"2011","unstructured":"Garraud O, Berthet J, Hamzeh-Cognasse H, Cognasse F (2011) Pathogen sensing, subsequent signalling, and signalosome in human platelets. Thromb Res 127:283\u2013286. https:\/\/doi.org\/10.1016\/j.thromres.2010.10.015","journal-title":"Thromb Res"},{"key":"1296_CR58","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00054725-200002000-00002","volume":"6","author":"C Gasche","year":"2000","unstructured":"Gasche C, Scholmerich J, Brynskov J, D\u2019Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, Sutherland LR (2000) A simple classification of Crohn\u2019s disease: report of the working party for the world congresses of gastroenterology, Vienna 1998. Inflamm Bowel Dis 6:8\u201315. https:\/\/doi.org\/10.1097\/00054725-200002000-00002","journal-title":"Inflamm Bowel Dis"},{"key":"1296_CR59","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/S0140-6736(06)68345-1","volume":"367","author":"DR Gaya","year":"2006","unstructured":"Gaya DR, Russell RK, Nimmo ER, Satsangi J (2006) New genes in inflammatory bowel disease: lessons for complex diseases? Lancet 367:1271\u20131284. https:\/\/doi.org\/10.1016\/S0140-6736(06)68345-1","journal-title":"Lancet"},{"key":"1296_CR60","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1084\/jem.20101712","volume":"208","author":"A Geremia","year":"2011","unstructured":"Geremia A, Arancibia-Carcamo CV, Fleming MP, Rust N, Singh B, Mortensen NJ, Travis SP, Powrie F (2011) IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med 208:1127\u20131133. https:\/\/doi.org\/10.1084\/jem.20101712","journal-title":"J Exp Med"},{"key":"1296_CR61","doi-asserted-by":"publisher","first-page":"8869","DOI":"10.1074\/jbc.C200651200","volume":"278","author":"SE Girardin","year":"2003","unstructured":"Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 278:8869\u20138872. https:\/\/doi.org\/10.1074\/jbc.C200651200","journal-title":"J Biol Chem"},{"key":"1296_CR62","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1182\/blood-2002-09-2797","volume":"101","author":"DV Gnatenko","year":"2003","unstructured":"Gnatenko DV, Dunn JJ, McCorkle SR, Weissmann D, Perrotta PL, Bahou WF (2003) Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 101:2285\u20132293. https:\/\/doi.org\/10.1182\/blood-2002-09-2797","journal-title":"Blood"},{"key":"1296_CR63","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1146\/annurev.immunol.16.1.111","volume":"16","author":"IS Grewal","year":"1998","unstructured":"Grewal IS, Flavell RA (1998) CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 16:111\u2013135. https:\/\/doi.org\/10.1146\/annurev.immunol.16.1.111","journal-title":"Annu Rev Immunol"},{"key":"1296_CR64","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.clim.2014.05.001","volume":"153","author":"NC Gunaydin","year":"2014","unstructured":"Gunaydin NC, Chou J, Karaca NE, Aksu G, Massaad MJ, Azarsiz E, Ertan Y, Geha RS, Kutukculer N (2014) A novel disease-causing CD40L mutation reduces expression of CD40 ligand, but preserves CD40 binding capacity. Clin Immunol 153:288\u2013291. https:\/\/doi.org\/10.1016\/j.clim.2014.05.001","journal-title":"Clin Immunol"},{"key":"1296_CR65","first-page":"296","volume":"13","author":"SB Hanauer","year":"2017","unstructured":"Hanauer SB (2017) Combination therapy for inflammatory bowel disease. Gastroenterol Hepatol NY 13:296\u2013298","journal-title":"Gastroenterol Hepatol NY"},{"key":"1296_CR66","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/35393","volume":"391","author":"V Henn","year":"1998","unstructured":"Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, Kroczek RA (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591\u2013594. https:\/\/doi.org\/10.1038\/35393","journal-title":"Nature"},{"key":"1296_CR67","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1182\/blood.v98.4.1047","volume":"98","author":"V Henn","year":"2001","unstructured":"Henn V, Steinbach S, Buchner K, Presek P, Kroczek RA (2001) The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 98:1047\u20131054. https:\/\/doi.org\/10.1182\/blood.v98.4.1047","journal-title":"Blood"},{"key":"1296_CR68","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s00535-005-1744-3","volume":"41","author":"T Hibi","year":"2006","unstructured":"Hibi T, Ogata H (2006) Novel pathophysiological concepts of inflammatory bowel disease. J Gastroenterol 41:10\u201316. https:\/\/doi.org\/10.1007\/s00535-005-1744-3","journal-title":"J Gastroenterol"},{"key":"1296_CR69","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/ibd.21478","volume":"17","author":"SA Hirota","year":"2011","unstructured":"Hirota SA, Ng J, Lueng A, Khajah M, Parhar K, Li Y, Lam V, Potentier MS, Ng K, Bawa M, McCafferty DM, Rioux KP, Ghosh S, Xavier RJ, Colgan SP, Tschopp J, Muruve D, MacDonald JA, Beck PL (2011) NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis. Inflamm Bowel Dis 17:1359\u20131372. https:\/\/doi.org\/10.1002\/ibd.21478","journal-title":"Inflamm Bowel Dis"},{"key":"1296_CR70","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/0192-0561(88)90055-0","volume":"10","author":"SK Hu","year":"1988","unstructured":"Hu SK, Mitcho YL, Rath NC (1988) Effect of estradiol on interleukin 1 synthesis by macrophages. Int J Immunopharmacol 10:247\u2013252. https:\/\/doi.org\/10.1016\/0192-0561(88)90055-0","journal-title":"Int J Immunopharmacol"},{"key":"1296_CR71","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1161\/01.RES.0000070111.98158.6C","volume":"92","author":"DP Inwald","year":"2003","unstructured":"Inwald DP, McDowall A, Peters MJ, Callard RE, Klein NJ (2003) CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation. Circ Res 92:1041\u20131048. https:\/\/doi.org\/10.1161\/01.RES.0000070111.98158.6C","journal-title":"Circ Res"},{"key":"1296_CR72","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1600-0714.1988.tb01515.x","volume":"17","author":"JJ Jandinski","year":"1988","unstructured":"Jandinski JJ (1988) Osteoclast activating factor is now interleukin-1 beta: historical perspective and biological implications. J Oral Pathol 17:145\u2013152. https:\/\/doi.org\/10.1111\/j.1600-0714.1988.tb01515.x","journal-title":"J Oral Pathol"},{"key":"1296_CR73","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/ijlh.12084","volume":"35","author":"CN Jenne","year":"2013","unstructured":"Jenne CN, Urrutia R, Kubes P (2013) Platelets: bridging hemostasis, inflammation, and immunity. Int J Lab Hematol 35:254\u2013261. https:\/\/doi.org\/10.1111\/ijlh.12084","journal-title":"Int J Lab Hematol"},{"key":"1296_CR74","doi-asserted-by":"publisher","first-page":"e407","DOI":"10.1016\/j.crohns.2013.01.012","volume":"7","author":"SP Jorgensen","year":"2013","unstructured":"Jorgensen SP, Hvas CL, Agnholt J, Christensen LA, Heickendorff L, Dahlerup JF (2013) Active Crohn\u2019s disease is associated with low vitamin D levels. J Crohns Colitis 7:e407\u2013e413. https:\/\/doi.org\/10.1016\/j.crohns.2013.01.012","journal-title":"J Crohns Colitis"},{"key":"1296_CR75","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nature11582","volume":"491","author":"Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brand S, Buning C, Cohain A, Cichon S, D\u2019Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, Hawkey C, Hedl M, Hu X, Karlsen TH, Kupcinskas L, Kugathasan S, Latiano A, Laukens D, Lawrance IC, Lees CW, Louis E, Mahy G, Mansfield J, Morgan AR, Mowat C, Newman W, Palmieri O, Ponsioen CY, Potocnik U, Prescott NJ, Regueiro M, Rotter JI, Russell RK, Sanderson JD, Sans M, Satsangi J, Schreiber S, Simms LA, Sventoraityte J, Targan SR, Taylor KD, Tremelling M, Verspaget HW, De Vos M, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK, Zhao H, International IBDGC, Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux JD, Schadt EE, Daly MJ, Franke A, Parkes M, Vermeire S, Barrett JC, Cho JH","year":"2012","unstructured":"Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brand S, Buning C, Cohain A, Cichon S, D\u2019Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, Hawkey C, Hedl M, Hu X, Karlsen TH, Kupcinskas L, Kugathasan S, Latiano A, Laukens D, Lawrance IC, Lees CW, Louis E, Mahy G, Mansfield J, Morgan AR, Mowat C, Newman W, Palmieri O, Ponsioen CY, Potocnik U, Prescott NJ, Regueiro M, Rotter JI, Russell RK, Sanderson JD, Sans M, Satsangi J, Schreiber S, Simms LA, Sventoraityte J, Targan SR, Taylor KD, Tremelling M, Verspaget HW, De Vos M, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK, Zhao H, International IBDGC, Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux JD, Schadt EE, Daly MJ, Franke A, Parkes M, Vermeire S, Barrett JC, Cho JH (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491:119\u2013124. https:\/\/doi.org\/10.1038\/nature11582","journal-title":"Nature"},{"key":"1296_CR76","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.cppeds.2014.10.003","volume":"44","author":"A Kaistha","year":"2014","unstructured":"Kaistha A, Levine J (2014) Inflammatory bowel disease: the classic gastrointestinal autoimmune disease. Curr Probl Pediatr Adolesc Health Care 44:328\u2013334. https:\/\/doi.org\/10.1016\/j.cppeds.2014.10.003","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"1296_CR77","doi-asserted-by":"publisher","first-page":"695","DOI":"10.5604\/12321966.1185778","volume":"22","author":"B Kaminska","year":"2015","unstructured":"Kaminska B, Roszko-Kirpsza I, Landowski P, Szlagatys-Sidorkiewicz A, Guzinska-Ustymowicz K, Maciorkowska E (2015) Evaluation of CD40 and CD80 receptors in the colonic mucosal membrane of children with inflammatory bowel disease. Ann Agric Enviorn Med 22:695\u2013699. https:\/\/doi.org\/10.5604\/12321966.1185778","journal-title":"Ann Agric Enviorn Med"},{"key":"1296_CR78","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.addr.2018.12.005","volume":"141","author":"JL Karnell","year":"2019","unstructured":"Karnell JL, Rieder SA, Ettinger R, Kolbeck R (2019) Targeting the CD40-CD40L pathway in autoimmune diseases: humoral immunity and beyond. Adv Drug Deliv Rev 141:92\u2013103. https:\/\/doi.org\/10.1016\/j.addr.2018.12.005","journal-title":"Adv Drug Deliv Rev"},{"key":"1296_CR79","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1365-2036.2005.02526.x","volume":"22","author":"A Kasran","year":"2005","unstructured":"Kasran A, Boon L, Wortel CH, Hogezand RA, Schreiber S, Goldin E, Boer M, Geboes K, Rutgeerts P, Ceuppens JL (2005) Safety and tolerability of antagonist anti-human CD40 Mab ch5D12 in patients with moderate to severe Crohn\u2019s disease. Aliment Pharmacol Ther 22:111\u2013122. https:\/\/doi.org\/10.1111\/j.1365-2036.2005.02526.x","journal-title":"Aliment Pharmacol Ther"},{"key":"1296_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2018.03.004","author":"KH Katsanos","year":"2018","unstructured":"Katsanos KH, Papamichael K, Feuerstein JD, Christodoulou DK, Cheifetz AS (2018) Biological therapies in inflammatory bowel disease: beyond anti-TNF therapies. Clin Immunol. https:\/\/doi.org\/10.1016\/j.clim.2018.03.004","journal-title":"Clin Immunol"},{"key":"1296_CR81","doi-asserted-by":"publisher","DOI":"10.1080\/1354750X.2017.1387933","author":"TJ Kim","year":"2017","unstructured":"Kim TJ, Koo JS, Kim SJ, Hong SN, Kim YS, Yang SK, Kim YH (2017) Role of IL-1ra and Granzyme B as biomarkers in active Crohn\u2019s disease patients. Biomarkers. https:\/\/doi.org\/10.1080\/1354750X.2017.1387933","journal-title":"Biomarkers"},{"key":"1296_CR82","doi-asserted-by":"publisher","first-page":"e03677","DOI":"10.1161\/JAHA.118.009636","volume":"7","author":"K Kojok","year":"2018","unstructured":"Kojok K, Akoum SE, Mohsen M, Mourad W, Merhi Y (2018) CD40L priming of platelets via NF-kappaB activation is CD40- and TAK1-dependent. J Am Heart Assoc 7:e03677. https:\/\/doi.org\/10.1161\/JAHA.118.009636","journal-title":"J Am Heart Assoc"},{"key":"1296_CR83","doi-asserted-by":"publisher","first-page":"e013396","DOI":"10.1161\/JAHA.119.013396","volume":"9","author":"K Kojok","year":"2020","unstructured":"Kojok K, Mohsen M, El Kadiry AEH, Mourad W, Merhi Y (2020) Aspirin reduces the potentiating effect of CD40L on platelet aggregation via inhibition of myosin light chain. J Am Heart Assoc 9:e013396. https:\/\/doi.org\/10.1161\/JAHA.119.013396","journal-title":"J Am Heart Assoc"},{"key":"1296_CR84","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1097\/00042737-200411000-00011","volume":"16","author":"IE Koutroubakis","year":"2004","unstructured":"Koutroubakis IE, Theodoropoulou A, Xidakis C, Sfiridaki A, Notas G, Kolios G, Kouroumalis EA (2004) Association between enhanced soluble CD40 ligand and prothrombotic state in inflammatory bowel disease. Eur J Gastroenterol Hepatol 16:1147\u20131152. https:\/\/doi.org\/10.1097\/00042737-200411000-00011","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1296_CR85","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12876-018-0746-6","volume":"18","author":"Z Kurti","year":"2018","unstructured":"Kurti Z, Ilias A, Gonczi L, Vegh Z, Fadgyas-Freyler P, Korponay G, Golovics PA, Lovasz BD, Lakatos PL (2018) Therapeutic preferences and outcomes in newly diagnosed patients with Crohn\u2019s diseases in the biological era in Hungary: a nationwide study based on the National Health Insurance Fund database. BMC Gastroenterol 18:23. https:\/\/doi.org\/10.1186\/s12876-018-0746-6","journal-title":"BMC Gastroenterol"},{"key":"1296_CR86","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1016\/j.ajpath.2017.08.016","volume":"187","author":"P Kusters","year":"2017","unstructured":"Kusters P, Seijkens T, Burger C, Legein B, Winkels H, Gijbels M, Barthels C, Bennett R, Beckers L, Atzler D, Biessen E, Brocker T, Weber C, Gerdes N, Lutgens E (2017) Constitutive CD40 signaling in dendritic cells limits atherosclerosis by provoking inflammatory bowel disease and ensuing cholesterol malabsorption. Am J Pathol 187:2912\u20132919. https:\/\/doi.org\/10.1016\/j.ajpath.2017.08.016","journal-title":"Am J Pathol"},{"key":"1296_CR87","first-page":"1172","volume":"8","author":"M Lafage-Pochitaloff","year":"1994","unstructured":"Lafage-Pochitaloff M, Herman P, Birg F, Galizzi JP, Simonetti J, Mannoni P, Banchereau J (1994) Localization of the human CD40 gene to chromosome 20, bands q12\u2013q13.2. Leukemia 8:1172\u20131175","journal-title":"Leukemia"},{"key":"1296_CR88","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1155\/2006\/250490","volume":"20","author":"S Lal","year":"2006","unstructured":"Lal S, Steinhart AH (2006) Antibiotic therapy for Crohn\u2019s disease: a review. Can J Gastroenterol 20:651\u2013655. https:\/\/doi.org\/10.1155\/2006\/250490","journal-title":"Can J Gastroenterol"},{"key":"1296_CR89","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/ecco-jcc\/jjy170","volume":"13","author":"M Lampinen","year":"2019","unstructured":"Lampinen M, Vessby J, Fredricsson A, Wanders A, Rorsman F, Carlson M (2019) High serum sCD40 and a distinct colonic T cell profile in ulcerative colitis associated with primary sclerosing cholangitis. J Crohns Colitis 13:341\u2013350. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjy170","journal-title":"J Crohns Colitis"},{"key":"1296_CR90","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1095\/biolreprod.113.110056","volume":"89","author":"M Lappas","year":"2013","unstructured":"Lappas M (2013) NOD1 and NOD2 regulate proinflammatory and prolabor mediators in human fetal membranes and myometrium via nuclear factor-kappa B. Biol Reprod 89:14. https:\/\/doi.org\/10.1095\/biolreprod.113.110056","journal-title":"Biol Reprod"},{"key":"1296_CR91","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4188::AID-IMMU4188>3.0.CO;2-B","volume":"28","author":"JR Lee","year":"1998","unstructured":"Lee JR, Koretzky GA (1998) Production of reactive oxygen intermediates following CD40 ligation correlates with c-Jun N-terminal kinase activation and IL-6 secretion in murine B lymphocytes. Eur J Immunol 28:4188\u20134197. https:\/\/doi.org\/10.1002\/(SICI)1521-4141(199812)28:12%3c4188::AID-IMMU4188%3e3.0.CO;2-B","journal-title":"Eur J Immunol"},{"issue":"79\u201391","key":"1296_CR92","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1016\/j.cell.2019.11.026","volume":"180","author":"JY Lee","year":"2020","unstructured":"Lee JY, Hall JA, Kroehling L, Wu L, Najar T, Nguyen HH, Lin WY, Yeung ST, Silva HM, Li D, Hine A, Loke P, Hudesman D, Martin JC, Kenigsberg E, Merad M, Khanna KM, Littman DR (2020) Serum amyloid A proteins induce pathogenic Th17 cells and promote inflammatory disease. Cell 180(79\u201391):e16. https:\/\/doi.org\/10.1016\/j.cell.2019.11.026","journal-title":"Cell"},{"key":"1296_CR93","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/j.jacc.2008.07.032","volume":"52","author":"AS Leroyer","year":"2008","unstructured":"Leroyer AS, Rautou PE, Silvestre JS, Castier Y, Leseche G, Devue C, Duriez M, Brandes RP, Lutgens E, Tedgui A, Boulanger CM (2008) CD40 ligand+ microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization. J Am Coll Cardiol 52:1302\u20131311. https:\/\/doi.org\/10.1016\/j.jacc.2008.07.032","journal-title":"J Am Coll Cardiol"},{"key":"1296_CR94","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1093\/ecco-jcc\/jjw053","volume":"10","author":"AD Levin","year":"2016","unstructured":"Levin AD, Wildenberg ME, van den Brink GR (2016) Mechanism of action of anti-TNF therapy in inflammatory bowel disease. J Crohns Colitis 10:989\u2013997. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw053","journal-title":"J Crohns Colitis"},{"key":"1296_CR95","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1097\/MIB.0000000000000554","volume":"21","author":"Z Li","year":"2015","unstructured":"Li Z, Vermeire S, Bullens D, Ferrante M, Van Steen K, Noman M, Bossuyt X, Rutgeerts P, Ceuppens JL, Van Assche G (2015) Anti-tumor necrosis factor therapy restores peripheral blood B-cell subsets and CD40 expression in inflammatory bowel diseases. Inflamm Bowel Dis 21:2787\u20132796. https:\/\/doi.org\/10.1097\/MIB.0000000000000554","journal-title":"Inflamm Bowel Dis"},{"key":"1296_CR96","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1160\/TH09-01-0029","volume":"102","author":"D Lievens","year":"2009","unstructured":"Lievens D, Eijgelaar WJ, Biessen EA, Daemen MJ, Lutgens E (2009) The multi-functionality of CD40L and its receptor CD40 in atherosclerosis. Thromb Haemost 102:206\u2013214. https:\/\/doi.org\/10.1160\/TH09-01-0029","journal-title":"Thromb Haemost"},{"key":"1296_CR97","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.4049\/jimmunol.163.7.4049","volume":"163","author":"Z Liu","year":"1999","unstructured":"Liu Z, Colpaert S, D\u2019Haens GR, Kasran A, de Boer M, Rutgeerts P, Geboes K, Ceuppens JL (1999) Hyperexpression of CD40 ligand (CD154) in inflammatory bowel disease and its contribution to pathogenic cytokine production. J Immunol 163:4049\u20134057","journal-title":"J Immunol"},{"key":"1296_CR98","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1038\/s41385-019-0163-3","volume":"12","author":"G Liu","year":"2019","unstructured":"Liu G, Mateer SW, Hsu A, Goggins BJ, Tay H, Mathe A, Fan K, Neal R, Bruce J, Burns G, Minahan K, Maltby S, Fricker M, Foster PS, Wark PAB, Hansbro PM, Keely S (2019) Platelet activating factor receptor regulates colitis-induced pulmonary inflammation through the NLRP3 inflammasome. Mucosal Immunol 12:862\u2013873. https:\/\/doi.org\/10.1038\/s41385-019-0163-3","journal-title":"Mucosal Immunol"},{"key":"1296_CR99","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","volume":"6","author":"J Liu","year":"2020","unstructured":"Liu J, Cao R, Xu M, Wang X, Zhang H, Hu H, Li Y, Hu Z, Zhong W, Wang M (2020) Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov 6:16. https:\/\/doi.org\/10.1038\/s41421-020-0156-0","journal-title":"Cell Discov"},{"key":"1296_CR100","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/ng.3359","volume":"47","author":"Liu JZ, van Sommeren S, Huang H, Ng SC, Alberts R, Takahashi A, Ripke S, Lee JC, Jostins L, Shah T, Abedian S, Cheon JH, Cho J, Dayani NE, Franke L, Fuyuno Y, Hart A, Juyal RC, Juyal G, Kim WH, Morris AP, Poustchi H, Newman WG, Midha V, Orchard TR, Vahedi H, Sood A, Sung JY, Malekzadeh R, Westra HJ, Yamazaki K, Yang SK, International Multiple Sclerosis Genetics C, International IBDGC, Barrett JC, Alizadeh BZ, Parkes M, Bk T, Daly MJ, Kubo M, Anderson CA, Weersma RK","year":"2015","unstructured":"Liu JZ, van Sommeren S, Huang H, Ng SC, Alberts R, Takahashi A, Ripke S, Lee JC, Jostins L, Shah T, Abedian S, Cheon JH, Cho J, Dayani NE, Franke L, Fuyuno Y, Hart A, Juyal RC, Juyal G, Kim WH, Morris AP, Poustchi H, Newman WG, Midha V, Orchard TR, Vahedi H, Sood A, Sung JY, Malekzadeh R, Westra HJ, Yamazaki K, Yang SK, International Multiple Sclerosis Genetics C, International IBDGC, Barrett JC, Alizadeh BZ, Parkes M, Bk T, Daly MJ, Kubo M, Anderson CA, Weersma RK (2015) Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet 47:979\u2013986. https:\/\/doi.org\/10.1038\/ng.3359","journal-title":"Nat Genet"},{"key":"1296_CR101","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/s0092-8674(01)00237-9","volume":"104","author":"RM Locksley","year":"2001","unstructured":"Locksley RM, Killeen N, Lenardo MJ (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487\u2013501. https:\/\/doi.org\/10.1016\/s0092-8674(01)00237-9","journal-title":"Cell"},{"key":"1296_CR102","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1093\/ibd\/izx098","volume":"24","author":"E Louis","year":"2018","unstructured":"Louis E (2018) Stopping biologics in IBD-what is the evidence? Inflamm Bowel Dis 24:725\u2013731. https:\/\/doi.org\/10.1093\/ibd\/izx098","journal-title":"Inflamm Bowel Dis"},{"key":"1296_CR103","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1007\/s00384-002-0425-4","volume":"18","author":"O Ludwiczek","year":"2003","unstructured":"Ludwiczek O, Kaser A, Tilg H (2003) Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases. Int J Colorectal Dis 18:142\u2013147. https:\/\/doi.org\/10.1007\/s00384-002-0425-4","journal-title":"Int J Colorectal Dis"},{"key":"1296_CR104","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s10620-018-4932-8","volume":"63","author":"J Luther","year":"2018","unstructured":"Luther J, Gala M, Patel SJ, Dave M, Borren N, Xavier RJ, Ananthakrishnan AN (2018) Loss of response to anti-tumor necrosis factor alpha therapy in Crohn\u2019s disease is not associated with emergence of novel inflammatory pathways. Dig Sci 63:738\u2013745. https:\/\/doi.org\/10.1007\/s10620-018-4932-8","journal-title":"Dig Sci"},{"key":"1296_CR105","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/ecco-jcc\/jjw051","volume":"10","author":"MK Magnusson","year":"2016","unstructured":"Magnusson MK, Strid H, Sapnara M, Lasson A, Bajor A, Ung KA, Ohman L (2016) Anti-TNF therapy response in patients with ulcerative colitis is associated with colonic antimicrobial peptide expression and microbiota composition. J Crohns Colitis 10:943\u2013952. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjw051","journal-title":"J Crohns Colitis"},{"key":"1296_CR106","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.3748\/wjg.v20.i17.4857","volume":"20","author":"F Magro","year":"2014","unstructured":"Magro F, Soares JB, Fernandes D (2014) Venous thrombosis and prothrombotic factors in inflammatory bowel disease. World J Gastroenterol 20:4857\u20134872. https:\/\/doi.org\/10.3748\/wjg.v20.i17.4857","journal-title":"World J Gastroenterol"},{"key":"1296_CR107","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.3389\/fimmu.2018.02566","volume":"9","author":"L Mao","year":"2018","unstructured":"Mao L, Kitani A, Strober W, Fuss IJ (2018) The role of NLRP3 and IL-1beta in the pathogenesis of inflammatory bowel disease. Front Immunol 9:2566. https:\/\/doi.org\/10.3389\/fimmu.2018.02566","journal-title":"Front Immunol"},{"key":"1296_CR108","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.cyto.2015.03.022","volume":"74","author":"M Monteleone","year":"2015","unstructured":"Monteleone M, Stow JL, Schroder K (2015) Mechanisms of unconventional secretion of IL-1 family cytokines. Cytokine 74:213\u2013218. https:\/\/doi.org\/10.1016\/j.cyto.2015.03.022","journal-title":"Cytokine"},{"key":"1296_CR109","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.7326\/0003-4819-68-5-1013","volume":"68","author":"DA Morowitz","year":"1968","unstructured":"Morowitz DA, Allen LW, Kirsner JB (1968) Thrombocytosis in chronic inflammatory bowel disease. Ann Intern Med 68:1013\u20131021. https:\/\/doi.org\/10.7326\/0003-4819-68-5-1013","journal-title":"Ann Intern Med"},{"key":"1296_CR110","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/gastro\/gou087","volume":"3","author":"AC Moss","year":"2015","unstructured":"Moss AC (2015) Optimizing the use of biological therapy in patients with inflammatory bowel disease. Gastroenterol Rep Oxf 3:63\u201368. https:\/\/doi.org\/10.1093\/gastro\/gou087","journal-title":"Gastroenterol Rep Oxf"},{"key":"1296_CR111","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.1182\/blood-2010-09-299719","volume":"117","author":"S Nagalla","year":"2011","unstructured":"Nagalla S, Shaw C, Kong X, Kondkar AA, Edelstein LC, Ma L, Chen J, McKnight GS, Lopez JA, Yang L, Jin Y, Bray MS, Leal SM, Dong JF, Bray PF (2011) Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity. Blood 117:5189\u20135197. https:\/\/doi.org\/10.1182\/blood-2010-09-299719","journal-title":"Blood"},{"key":"1296_CR112","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/s0968-0004(97)01164-x","volume":"23","author":"JH Naismith","year":"1998","unstructured":"Naismith JH, Sprang SR (1998) Modularity in the TNF-receptor family. Trends Biochem Sci 23:74\u201379. https:\/\/doi.org\/10.1016\/s0968-0004(97)01164-x","journal-title":"Trends Biochem Sci"},{"key":"1296_CR113","doi-asserted-by":"publisher","first-page":"420","DOI":"10.5009\/gnl17236","volume":"12","author":"A Nakarai","year":"2018","unstructured":"Nakarai A, Kato J, Hiraoka S, Takashima S, Inokuchi T, Takahara M, Sugihara Y, Harada K, Okada H (2018) An elevated platelet count increases the risk of relapse in ulcerative colitis patients with mucosal healing. Gut Liver 12:420\u2013425. https:\/\/doi.org\/10.5009\/gnl17236","journal-title":"Gut Liver"},{"key":"1296_CR114","first-page":"3532","volume":"13","author":"AT Nurden","year":"2008","unstructured":"Nurden AT, Nurden P, Sanchez M, Andia I, Anitua E (2008) Platelets and wound healing. Front Biosci 13:3532\u20133548","journal-title":"Front Biosci"},{"key":"1296_CR115","doi-asserted-by":"publisher","first-page":"e0210998","DOI":"10.1371\/journal.pone.0210998","volume":"14","author":"A Ogrinc Wagner","year":"2019","unstructured":"Ogrinc Wagner A, Friedrich V, Barthels C, Marconi P, Blutke A, Brombacher F, Brocker T (2019) Strain specific maturation of dendritic cells and production of IL-1beta controls CD40-driven colitis. PLoS ONE 14:e0210998. https:\/\/doi.org\/10.1371\/journal.pone.0210998","journal-title":"PLoS ONE"},{"key":"1296_CR116","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3748\/wjg.v22.i3.895","volume":"22","author":"D Owczarek","year":"2016","unstructured":"Owczarek D, Rodacki T, Domagala-Rodacka R, Cibor D, Mach T (2016) Diet and nutritional factors in inflammatory bowel diseases. World J Gastroenterol 22:895\u2013905. https:\/\/doi.org\/10.3748\/wjg.v22.i3.895","journal-title":"World J Gastroenterol"},{"key":"1296_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17101723","author":"S Pankratz","year":"2016","unstructured":"Pankratz S, Bittner S, Kehrel BE, Langer HF, Kleinschnitz C, Meuth SG, Gobel K (2016) The inflammatory role of platelets: translational insights from experimental studies of autoimmune disorders. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms17101723","journal-title":"Int J Mol Sci"},{"key":"1296_CR118","doi-asserted-by":"publisher","first-page":"6712901","DOI":"10.1155\/2018\/6712901","volume":"2018","author":"SA Paschou","year":"2018","unstructured":"Paschou SA, Kothonas F, Lafkas A, Myroforidis A, Loi V, Terzi T, Karagianni O, Poulou A, Goumas K, Vryonidou A (2018) Favorable effect of anti-TNF therapy on insulin sensitivity in nonobese, nondiabetic patients with inflammatory bowel disease. Int J Endocrinol 2018:6712901. https:\/\/doi.org\/10.1155\/2018\/6712901","journal-title":"Int J Endocrinol"},{"key":"1296_CR119","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/00004836-199310000-00013","volume":"17","author":"MA Peppercorn","year":"1993","unstructured":"Peppercorn MA (1993) Is there a role for antibiotics as primary therapy in Crohn\u2019s ileitis? J Clin Gastroenterol 17:235\u2013237","journal-title":"J Clin Gastroenterol"},{"key":"1296_CR120","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13075-017-1443-5","volume":"19","author":"SF Perazzio","year":"2017","unstructured":"Perazzio SF, Soeiro-Pereira PV, Dos Santos VC, de Brito MV, Salu B, Oliva MLV, Stevens AM, de Souza AWS, Ochs HD, Torgerson TR, Condino-Neto A, Andrade LEC (2017) Soluble CD40L is associated with increased oxidative burst and neutrophil extracellular trap release in Behcet\u2019s disease. Arthritis Res Ther 19:235. https:\/\/doi.org\/10.1186\/s13075-017-1443-5","journal-title":"Arthritis Res Ther"},{"key":"1296_CR121","doi-asserted-by":"publisher","first-page":"451","DOI":"10.5152\/tjg.2020.19454","volume":"31","author":"SS Petrovic","year":"2020","unstructured":"Petrovic SS, Vasiljevska MM, Obradovic SD, Tarabar DK, Doder RB, Majstorovic IJ, Petrovic MD, Magic ZM, Cikota BM, Perisic NJ, Brcerevic IA, Manojlovic NS, Rancic NK (2020) Antiplatelet agents\u2019-ticagrelol and eptifibatide-safety in experimental colitis in mice. Turk J Gastroenterol 31:451\u2013458. https:\/\/doi.org\/10.5152\/tjg.2020.19454","journal-title":"Turk J Gastroenterol"},{"key":"1296_CR122","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nri3565","volume":"14","author":"DJ Philpott","year":"2014","unstructured":"Philpott DJ, Sorbara MT, Robertson SJ, Croitoru K, Girardin SE (2014) NOD proteins: regulators of inflammation in health and disease. Nat Rev Immunol 14:9\u201323. https:\/\/doi.org\/10.1038\/nri3565","journal-title":"Nat Rev Immunol"},{"key":"1296_CR123","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1160\/TH12-03-0153","volume":"108","author":"H Ple","year":"2012","unstructured":"Ple H, Maltais M, Corduan A, Rousseau G, Madore F, Provost P (2012) Alteration of the platelet transcriptome in chronic kidney disease. Thromb Haemost 108:605\u2013615. https:\/\/doi.org\/10.1160\/TH12-03-0153","journal-title":"Thromb Haemost"},{"key":"1296_CR124","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/00042737-200203000-00006","volume":"14","author":"L Polese","year":"2002","unstructured":"Polese L, Angriman I, Cecchetto A, Norberto L, Scarpa M, Ruffolo C, Barollo M, Sommariva A, D\u2019Amico DF (2002) The role of CD40 in ulcerative colitis: histochemical analysis and clinical correlation. Eur J Gastroenterol Hepatol 14:237\u2013241. https:\/\/doi.org\/10.1097\/00042737-200203000-00006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1296_CR125","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1200\/JCO.2017.76.4662","volume":"36","author":"SP Rachakonda","year":"2018","unstructured":"Rachakonda SP, Dai H, Penack O, Blau O, Blau IW, Radujkovic A, Muller-Tidow C, Kumar R, Dreger P, Luft T (2018) Single nucleotide polymorphisms in CD40L predict endothelial complications and mortality after allogeneic stem-cell transplantation. J Clin Oncol 36:789\u2013800. https:\/\/doi.org\/10.1200\/JCO.2017.76.4662","journal-title":"J Clin Oncol"},{"key":"1296_CR126","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1080\/09537100120068170","volume":"12","author":"F Rendu","year":"2001","unstructured":"Rendu F, Brohard-Bohn B (2001) The platelet release reaction: granules\u2019 constituents, secretion and functions. Platelets 12:261\u2013273. https:\/\/doi.org\/10.1080\/09537100120068170","journal-title":"Platelets"},{"key":"1296_CR127","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/sj.ejcn.1600556","volume":"52","author":"AM Riordan","year":"1998","unstructured":"Riordan AM, Ruxton CH, Hunter JO (1998) A review of associations between Crohn\u2019s disease and consumption of sugars. Eur J Clin Nutr 52:229\u2013238. https:\/\/doi.org\/10.1038\/sj.ejcn.1600556","journal-title":"Eur J Clin Nutr"},{"key":"1296_CR128","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.clinre.2011.02.012","volume":"35","author":"J Ripoche","year":"2011","unstructured":"Ripoche J (2011) Blood platelets and inflammation: their relationship with liver and digestive diseases. Clin Res Hepatol Gastroenterol 35:353\u2013357. https:\/\/doi.org\/10.1016\/j.clinre.2011.02.012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"1296_CR129","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.molmed.2008.09.006","volume":"14","author":"M Rizvi","year":"2008","unstructured":"Rizvi M, Pathak D, Freedman JE, Chakrabarti S (2008) CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease. Trends Mol Med 14:530\u2013538. https:\/\/doi.org\/10.1016\/j.molmed.2008.09.006","journal-title":"Trends Mol Med"},{"key":"1296_CR130","first-page":"541","volume":"83","author":"A Rosen","year":"1982","unstructured":"Rosen A, Ursing B, Alm T, Barany F, Bergelin I, Ganrot-Norlin K, Hoevels J, Huitfeldt B, Jarnerot G, Krause U, Krook A, Lindstrom B, Nordle O (1982) A comparative study of metronidazole and sulfasalazine for active Crohn\u2019s disease: the cooperative Crohn\u2019s disease study in Sweden. I Des Methodologic Considerations Gastroenterol 83:541\u2013549","journal-title":"I Des Methodologic Considerations Gastroenterol"},{"key":"1296_CR131","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1182\/blood-2011-03-339705","volume":"118","author":"JW Rowley","year":"2011","unstructured":"Rowley JW, Oler AJ, Tolley ND, Hunter BN, Low EN, Nix DA, Yost CC, Zimmerman GA, Weyrich AS (2011) Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood 118:e101\u2013e111. https:\/\/doi.org\/10.1182\/blood-2011-03-339705","journal-title":"Blood"},{"key":"1296_CR132","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1186\/s13104-017-2824-1","volume":"10","author":"MA Ruiz","year":"2017","unstructured":"Ruiz MA, Kaiser RL Jr, de Quadros LG, Piron-Ruiz L, Pena-Arciniegas T, Faria MAG, Siqueira RC, Pirozzi FF, Kaiser FSL, Burt RK (2017) Low toxicity and favorable clinical and quality of life impact after non-myeloablative autologous hematopoietic stem cell transplant in Crohn\u2019s disease. BMC Res Notes 10:495. https:\/\/doi.org\/10.1186\/s13104-017-2824-1","journal-title":"BMC Res Notes"},{"key":"1296_CR133","doi-asserted-by":"publisher","first-page":"384","DOI":"10.5604\/17322693.1098145","volume":"68","author":"J Saluk","year":"2014","unstructured":"Saluk J, Bijak M, Ponczek MB, Wachowicz B (2014) The formation, metabolism and the evolution of blood platelets. Postepy Hig Med Dosw Online 68:384\u2013391. https:\/\/doi.org\/10.5604\/17322693.1098145","journal-title":"Postepy Hig Med Dosw Online"},{"key":"1296_CR134","first-page":"438","volume":"12","author":"WJ Sandborn","year":"2016","unstructured":"Sandborn WJ (2016) The present and future of inflammatory bowel disease treatment. Gastroenterol Hepatol N 12:438\u2013441","journal-title":"Gastroenterol Hepatol N"},{"key":"1296_CR135","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMc1707500","volume":"377","author":"WJ Sandborn","year":"2017","unstructured":"Sandborn WJ, Su C, Panes J (2017) Tofacitinib as induction and maintenance therapy for ulcerative colitis. N Engl J Med 377:496\u2013497. https:\/\/doi.org\/10.1056\/NEJMc1707500","journal-title":"N Engl J Med"},{"issue":"77\u201386","key":"1296_CR136","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1053\/j.gastro.2017.03.049","volume":"153","author":"BE Sands","year":"2017","unstructured":"Sands BE, Chen J, Feagan BG, Penney M, Rees WA, Danese S, Higgins PDR, Newbold P, Faggioni R, Patra K, Li J, Klekotka P, Morehouse C, Pulkstenis E, Drappa J, van der Merwe R, Gasser RA Jr (2017) Efficacy and safety of MEDI2070, an antibody against interleukin 23, in patients with moderate to severe Crohn\u2019s disease: a phase 2a study. Gastroenterology 153(77\u201386):e6. https:\/\/doi.org\/10.1053\/j.gastro.2017.03.049","journal-title":"Gastroenterology"},{"key":"1296_CR137","doi-asserted-by":"publisher","first-page":"4445","DOI":"10.1021\/acs.biochem.7b00470","volume":"56","author":"AK Schaefer","year":"2017","unstructured":"Schaefer AK, Wastyk HC, Mohanan V, Hou CW, Lauro ML, Melnyk JE, Burch JM, Grimes CL (2017) Crohn\u2019s disease variants of Nod2 are stabilized by the critical contact region of Hsp70. Biochemistry 56:4445\u20134448. https:\/\/doi.org\/10.1021\/acs.biochem.7b00470","journal-title":"Biochemistry"},{"key":"1296_CR138","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/s1357-2725(00)00016-9","volume":"32","author":"U Schonbeck","year":"2000","unstructured":"Schonbeck U, Mach F, Libby P (2000) CD154 (CD40 ligand). Int J Biochem Cell Biol 32:687\u2013693. https:\/\/doi.org\/10.1016\/s1357-2725(00)00016-9","journal-title":"Int J Biochem Cell Biol"},{"key":"1296_CR139","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00018-009-0205-1","volume":"67","author":"JW Semple","year":"2010","unstructured":"Semple JW, Freedman J (2010) Platelets and innate immunity. Cell Mol Life Sci 67:499\u2013511. https:\/\/doi.org\/10.1007\/s00018-009-0205-1","journal-title":"Cell Mol Life Sci"},{"key":"1296_CR140","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nri2956","volume":"11","author":"JW Semple","year":"2011","unstructured":"Semple JW, Italiano JE Jr, Freedman J (2011) Platelets and the immune continuum. Nat Rev Immunol 11:264\u2013274. https:\/\/doi.org\/10.1038\/nri2956","journal-title":"Nat Rev Immunol"},{"key":"1296_CR141","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3389\/fimmu.2015.00529","volume":"6","author":"N Senhaji","year":"2015","unstructured":"Senhaji N, Kojok K, Darif Y, Fadainia C, Zaid Y (2015) The contribution of CD40\/CD40L axis in inflammatory bowel disease: an update. Front Immunol 6:529. https:\/\/doi.org\/10.3389\/fimmu.2015.00529","journal-title":"Front Immunol"},{"key":"1296_CR142","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1053\/j.gastro.2014.01.050","volume":"146","author":"F Shanahan","year":"2014","unstructured":"Shanahan F, Quigley EM (2014) Manipulation of the microbiota for treatment of IBS and IBD-challenges and controversies. Gastroenterology 146:1554\u20131563. https:\/\/doi.org\/10.1053\/j.gastro.2014.01.050","journal-title":"Gastroenterology"},{"key":"1296_CR143","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5152\/tjg.2020.181028","volume":"31","author":"A Sharifi","year":"2020","unstructured":"Sharifi A, Vahedi H, Honarvar MR, Amiriani T, Nikniaz Z, Rad EY, Hosseinzadeh-Attar MJ (2020) Vitamin D decreases CD40L gene expression in ulcerative colitis patients: a randomized, double-blinded, placebo-controlled trial. Turk J Gastroenterol 31:99\u2013104. https:\/\/doi.org\/10.5152\/tjg.2020.181028","journal-title":"Turk J Gastroenterol"},{"key":"1296_CR144","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3748\/wjg.14.390","volume":"14","author":"DQ Shih","year":"2008","unstructured":"Shih DQ, Targan SR (2008) Immunopathogenesis of inflammatory bowel disease. World J Gastroenterol 14:390\u2013400","journal-title":"World J Gastroenterol"},{"key":"1296_CR145","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/nri1226","volume":"3","author":"K Shuai","year":"2003","unstructured":"Shuai K, Liu B (2003) Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol 3:900\u2013911. https:\/\/doi.org\/10.1038\/nri1226","journal-title":"Nat Rev Immunol"},{"issue":"Suppl A","key":"1296_CR146","doi-asserted-by":"publisher","first-page":"5A","DOI":"10.1155\/2005\/269076","volume":"19","author":"MS Silverberg","year":"2005","unstructured":"Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF, Gasche C, Geboes K, Jewell DP, Karban A, Loftus EV Jr, Pena AS, Riddell RH, Sachar DB, Schreiber S, Steinhart AH, Targan SR, Vermeire S, Warren BF (2005) Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19(Suppl A):5A-36A. https:\/\/doi.org\/10.1155\/2005\/269076","journal-title":"Can J Gastroenterol"},{"key":"1296_CR147","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1182\/blood-2013-12-544692","volume":"123","author":"LM Simon","year":"2014","unstructured":"Simon LM, Edelstein LC, Nagalla S, Woodley AB, Chen ES, Kong X, Ma L, Fortina P, Kunapuli S, Holinstat M, McKenzie SE, Dong JF, Shaw CA, Bray PF (2014) Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics. Blood 123:e37-45. https:\/\/doi.org\/10.1182\/blood-2013-12-544692","journal-title":"Blood"},{"key":"1296_CR148","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nri2691","volume":"10","author":"JE Sims","year":"2010","unstructured":"Sims JE, Smith DE (2010) The IL-1 family: regulators of immunity. Nat Rev Immunol 10:89\u2013102. https:\/\/doi.org\/10.1038\/nri2691","journal-title":"Nat Rev Immunol"},{"key":"1296_CR149","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1002\/pro.5560070506","volume":"7","author":"J Singh","year":"1998","unstructured":"Singh J, Garber E, Van Vlijmen H, Karpusas M, Hsu YM, Zheng Z, Naismith JH, Thomas D (1998) The role of polar interactions in the molecular recognition of CD40L with its receptor CD40. Protein Sci 7:1124\u20131135. https:\/\/doi.org\/10.1002\/pro.5560070506","journal-title":"Protein Sci"},{"key":"1296_CR150","doi-asserted-by":"publisher","first-page":"H689","DOI":"10.1152\/ajpheart.00962.2008","volume":"296","author":"KY Stokes","year":"2009","unstructured":"Stokes KY, Calahan L, Hamric CM, Russell JM, Granger DN (2009) CD40\/CD40L contributes to hypercholesterolemia-induced microvascular inflammation. Am J Physiol Heart Circ Physiol 296:H689\u2013H697. https:\/\/doi.org\/10.1152\/ajpheart.00962.2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1296_CR151","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8060149","author":"RC Su","year":"2020","unstructured":"Su RC, Warner EA, Breidenbach JD, Lad A, Blomquist TM, Kleinhenz AL, Modyanov N, Malhotra D, Kennedy DJ, Haller ST (2020) CD40 receptor knockout protects against microcystin-LR (MC-LR) prolongation and exacerbation of dextran sulfate sodium (DSS)-induced colitis. Biomedicines. https:\/\/doi.org\/10.3390\/biomedicines8060149","journal-title":"Biomedicines"},{"key":"1296_CR152","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-018-1437-3","author":"K Suzuki","year":"2018","unstructured":"Suzuki K, Murano T, Shimizu H, Ito G, Nakata T, Fujii S, Ishibashi F, Kawamoto A, Anzai S, Kuno R, Kuwabara K, Takahashi J, Hama M, Nagata S, Hiraguri Y, Takenaka K, Yui S, Tsuchiya K, Nakamura T, Ohtsuka K, Watanabe M, Okamoto R (2018) Single cell analysis of Crohn\u2019s disease patient-derived small intestinal organoids reveals disease activity-dependent modification of stem cell properties. J Gastroenterol. https:\/\/doi.org\/10.1007\/s00535-018-1437-3","journal-title":"J Gastroenterol"},{"key":"1296_CR153","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.alcohol.2009.10.019","volume":"44","author":"GR Swanson","year":"2010","unstructured":"Swanson GR, Sedghi S, Farhadi A, Keshavarzian A (2010) Pattern of alcohol consumption and its effect on gastrointestinal symptoms in inflammatory bowel disease. Alcohol 44:223\u2013228. https:\/\/doi.org\/10.1016\/j.alcohol.2009.10.019","journal-title":"Alcohol"},{"key":"1296_CR154","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/trf.14970","volume":"59","author":"S Tariket","year":"2019","unstructured":"Tariket S, Guerrero JA, Garraud O, Ghevaert C, Cognasse F (2019) Platelet alpha-granules modulate the inflammatory response under systemic lipopolysaccharide injection in mice. Transfusion (Paris) 59:32\u201338. https:\/\/doi.org\/10.1111\/trf.14970","journal-title":"Transfusion (Paris)"},{"key":"1296_CR155","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4149\/bll_2014_018","volume":"115","author":"Y Tekelioglu","year":"2014","unstructured":"Tekelioglu Y, Uzun H, Sisman G (2014) Activated platelets in patients suffering from inflammatory bowel disease. Bratisl Lek Listy 115:83\u201385. https:\/\/doi.org\/10.4149\/bll_2014_018","journal-title":"Bratisl Lek Listy"},{"key":"1296_CR156","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.3748\/wjg.14.1972","volume":"14","author":"MI Torres","year":"2008","unstructured":"Torres MI, Rios A (2008) Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy. World J Gastroenterol 14:1972\u20131980. https:\/\/doi.org\/10.3748\/wjg.14.1972","journal-title":"World J Gastroenterol"},{"key":"1296_CR157","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/ibd.20043","volume":"13","author":"JA Tuvlin","year":"2007","unstructured":"Tuvlin JA, Raza SS, Bracamonte S, Julian C, Hanauer SB, Nicolae DL, King AC, Cho JH (2007) Smoking and inflammatory bowel disease: trends in familial and sporadic cohorts. Inflamm Bowel Dis 13:573\u2013579. https:\/\/doi.org\/10.1002\/ibd.20043","journal-title":"Inflamm Bowel Dis"},{"key":"1296_CR158","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1161\/01.CIR.0000027107.54614.1A","volume":"106","author":"C Urbich","year":"2002","unstructured":"Urbich C, Dernbach E, Aicher A, Zeiher AM, Dimmeler S (2002) CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation 106:981\u2013986. https:\/\/doi.org\/10.1161\/01.CIR.0000027107.54614.1A","journal-title":"Circulation"},{"key":"1296_CR159","first-page":"550","volume":"83","author":"B Ursing","year":"1982","unstructured":"Ursing B, Alm T, Barany F, Bergelin I, Ganrot-Norlin K, Hoevels J, Huitfeldt B, Jarnerot G, Krause U, Krook A, Lindstrom B, Nordle O, Rosen A (1982) A comparative study of metronidazole and sulfasalazine for active Crohn\u2019s disease: the cooperative Crohn\u2019s disease study in Sweden. II Result Gastroenterol 83:550\u2013562","journal-title":"II Result Gastroenterol"},{"key":"1296_CR160","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jlb.67.1.2","volume":"67","author":"C van Kooten","year":"2000","unstructured":"van Kooten C, Banchereau J (2000) CD40-CD40 ligand. J Leukoc Biol 67:2\u201317. https:\/\/doi.org\/10.1002\/jlb.67.1.2","journal-title":"J Leukoc Biol"},{"key":"1296_CR161","doi-asserted-by":"publisher","first-page":"748","DOI":"10.3109\/00365521.2015.1033000","volume":"50","author":"MH Vatn","year":"2015","unstructured":"Vatn MH, Sandvik AK (2015) Inflammatory bowel disease. Scand J Gastroenterol 50:748\u2013762. https:\/\/doi.org\/10.3109\/00365521.2015.1033000","journal-title":"Scand J Gastroenterol"},{"key":"1296_CR162","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S0140-6736(16)32537-5","volume":"389","author":"S Vermeire","year":"2017","unstructured":"Vermeire S, Schreiber S, Petryka R, Kuehbacher T, Hebuterne X, Roblin X, Klopocka M, Goldis A, Wisniewska-Jarosinska M, Baranovsky A, Sike R, Stoyanova K, Tasset C, Van der Aa A, Harrison P (2017) Clinical remission in patients with moderate-to-severe Crohn\u2019s disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial. Lancet 389:266\u2013275. https:\/\/doi.org\/10.1016\/S0140-6736(16)32537-5","journal-title":"Lancet"},{"key":"1296_CR163","doi-asserted-by":"publisher","first-page":"3180","DOI":"10.3748\/wjg.v20.i12.3180","volume":"20","author":"E Voudoukis","year":"2014","unstructured":"Voudoukis E, Karmiris K, Koutroubakis IE (2014) Multipotent role of platelets in inflammatory bowel diseases: a clinical approach. World J Gastroenterol 20:3180\u20133190. https:\/\/doi.org\/10.3748\/wjg.v20.i12.3180","journal-title":"World J Gastroenterol"},{"key":"1296_CR164","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3748\/wjg.v20.i1.6","volume":"20","author":"KL Wallace","year":"2014","unstructured":"Wallace KL, Zheng LB, Kanazawa Y, Shih DQ (2014) Immunopathology of inflammatory bowel disease. World J Gastroenterol 20:6\u201321. https:\/\/doi.org\/10.3748\/wjg.v20.i1.6","journal-title":"World J Gastroenterol"},{"key":"1296_CR165","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1046\/j.1538-7836.2003.00304.x","volume":"1","author":"AS Weyrich","year":"2003","unstructured":"Weyrich AS, Lindemann S, Zimmerman GA (2003) The evolving role of platelets in inflammation. J Thromb Haemost 1:1897\u20131905. https:\/\/doi.org\/10.1046\/j.1538-7836.2003.00304.x","journal-title":"J Thromb Haemost"},{"key":"1296_CR166","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.3748\/wjg.v20.i12.3255","volume":"20","author":"XR Xu","year":"2014","unstructured":"Xu XR, Liu CQ, Feng BS, Liu ZJ (2014) Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease. World J Gastroenterol 20:3255\u20133264. https:\/\/doi.org\/10.3748\/wjg.v20.i12.3255","journal-title":"World J Gastroenterol"},{"key":"1296_CR167","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1161\/ATVBAHA.110.216143","volume":"30","author":"D Yacoub","year":"2010","unstructured":"Yacoub D, Hachem A, Theoret JF, Gillis MA, Mourad W, Merhi Y (2010) Enhanced levels of soluble CD40 ligand exacerbate platelet aggregation and thrombus formation through a CD40-dependent tumor necrosis factor receptor-associated factor-2\/Rac1\/p38 mitogen-activated protein kinase signaling pathway. Arter Thromb Vasc Biol 30:2424\u20132433. https:\/\/doi.org\/10.1161\/ATVBAHA.110.216143","journal-title":"Arter Thromb Vasc Biol"},{"key":"1296_CR168","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.120.317703","author":"Y Zaid","year":"2020","unstructured":"Zaid Y, Puhm F, Allaeys I, Naya A, Oudghiri M, Khalki L, Limami Y, Zaid N, Sadki K, Ben El Haj R, Mahir W, Belayachi L, Belefquih B, Benouda A, Cheikh A, Langlois MA, Cherrah Y, Flamand L, Guessous F, Boilard E (2020) Platelets can associate with SARS-CoV-2 RNA and are hyperactivated in COVID-19. Circ Res. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317703","journal-title":"Circ Res"},{"key":"1296_CR169","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/ibd.22965","volume":"19","author":"C Zallot","year":"2013","unstructured":"Zallot C, Quilliot D, Chevaux JB, Peyrin-Biroulet C, Gueant-Rodriguez RM, Freling E, Collet-Fenetrier B, Williet N, Ziegler O, Bigard MA, Gueant JL, Peyrin-Biroulet L (2013) Dietary beliefs and behavior among inflammatory bowel disease patients. Inflamm Bowel Dis 19:66\u201372. https:\/\/doi.org\/10.1002\/ibd.22965","journal-title":"Inflamm Bowel Dis"},{"key":"1296_CR170","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3748\/wjg.v20.i1.91","volume":"20","author":"YZ Zhang","year":"2014","unstructured":"Zhang YZ, Li YY (2014) Inflammatory bowel disease: pathogenesis. World J Gastroenterol 20:91\u201399. https:\/\/doi.org\/10.3748\/wjg.v20.i1.91","journal-title":"World J Gastroenterol"},{"key":"1296_CR171","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.imlet.2013.07.005","volume":"153","author":"B Zhang","year":"2013","unstructured":"Zhang B, Wu T, Chen M, Zhou Y, Yi D, Guo R (2013) The CD40\/CD40L system: a new therapeutic target for disease. Immunol Lett 153:58\u201361. https:\/\/doi.org\/10.1016\/j.imlet.2013.07.005","journal-title":"Immunol Lett"},{"key":"1296_CR172","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.molimm.2019.12.005","volume":"118","author":"M Zhao","year":"2020","unstructured":"Zhao M, Gu J, Wang Z (2020) B cells in Crohn\u2019s patients presented reduced IL-35 expression capacity. Mol Immunol 118:124\u2013131. https:\/\/doi.org\/10.1016\/j.molimm.2019.12.005","journal-title":"Mol Immunol"},{"key":"1296_CR173","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1161\/CIRCULATIONAHA.106.683201","volume":"115","author":"A Zirlik","year":"2007","unstructured":"Zirlik A, Maier C, Gerdes N, MacFarlane L, Soosairajah J, Bavendiek U, Ahrens I, Ernst S, Bassler N, Missiou A, Patko Z, Aikawa M, Schonbeck U, Bode C, Libby P, Peter K (2007) CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1. Circulation 115:1571\u20131580. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.683201","journal-title":"Circulation"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-020-01296-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-020-01296-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-020-01296-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T19:43:12Z","timestamp":1697485392000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-020-01296-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":173,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1296"],"URL":"https:\/\/doi.org\/10.1007\/s12272-020-01296-1","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"29 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that the research was conducted in the absence of any competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}